Home > Insider Trading > Filing (0000950142-21-003818)

Filing Details

Accession Number:: 0000950142-21-003818
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2021-11-24 18:34:21
Reporting Period:: 2021-11-23

Accepted Time:: 2021-11-24 18:34:21
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1832466	Alignment Healthcare Inc.	ALHC	()	NY

Insiders

Cik	Name	Reported Address	Director	Officer	Large Shareholder	Other
1162870	Warburg Pincus Llc	C/O Warburg Pincus Llc 450 Lexington Aveue New York NY 10017	Yes	No	Yes	No
1540385	Wp Global Llc	C/O Warburg Pincus Llc 55 East 52Nd Street, 33Rd Floor New York NY 10017	Yes	No	Yes	No
1658396	Warburg Pincus Private Equity Xii, L.p.	C/O Warburg Pincus Llc 450 Lexinton Avenue New York NY 10017	Yes	No	Yes	No
1658398	Warburg Pincus Private Equity Xii-B, L.p.	C/O Warburg Pincus 450 Lexington Avenue New York NY 10017	Yes	No	Yes	No
1658400	Warburg Pincus Private Equity Xii-D, L.p.	C/O Warburg Pincus 450 Lexington Avenue New York NY 10017	Yes	No	Yes	No
1658404	Warburg Pincus Private Equity Xii-E, L.p.	C/O Warburg Pincus 450 Lexington Avenue New York NY 10017	Yes	No	Yes	No
1658412	Warburg Pincus Xii Partners, L.p.	C/O Warburg Pincus Llc 450 Lexington Avenue New York NY 10017	Yes	No	Yes	No
1658414	Wp Xii Partners, L.p.	C/O Warburg Pincus, Llc. 450 Lexington Avenue New York NY 10017	Yes	No	Yes	No
1658787	Warburg Pincus Partners Ii, L.p.	C/O Warburg Pincus Llc 450 Lexington Avenue New York NY 10017	Yes	No	Yes	No
1672765	Warburg Pincus Xii, L.p.	C/O Warburg Pincus Llc 450 Lexington Avenue New York NY 10017	Yes	No	Yes	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock, Par Value $0.001 Per Share	Disposition	2021-11-23	2,033,936	$20.11	22,768,785	No	4	S	Indirect	See footnote

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Indirect	See footnote

Footnotes

Represents 1,310,079 shares of Common Stock sold by Warburg Pincus Private Equity XII, L.P., a Delaware limited partnership ("WP XII"), 262,845 shares of Common Stock sold by Warburg Pincus Private Equity XII-B, L.P., a Delaware limited partnership ("WP XII-B"), 37,811 shares of Common Stock sold by Warburg Pincus Private Equity XII-D, L.P., a Delaware limited partnership ("WP XII-D"), and 215,801 shares of Common Stock sold by Warburg Pincus Private Equity XII-E, L.P., a Delaware limited partnership ("WP XII-E"), 70,679 shares of Common Stock sold by WP XII Partners, L.P., a Delaware limited partnership ("WP XII Partners"), 136,721 shares of Common Stock sold by Warburg Pincus XII Partners, L.P., a Delaware limited partnership ("Warburg Pincus XII Partners") pursuant to a registered public offering that closed on November 23, 2021 (the "Transaction"), at a price of $20.1075 (net of underwriting discount).
Reflects securities held directly by WP XII, WP XII-B, WP XII-D, WP XII-E, WP XII Partners, and Warburg Pincus XII Partners (together with WP XII, WP XII-B, WP XII-D, WP XII-E, and WP XII Partners, the "WP XII Funds") following the closing of the Transaction. Warburg Pincus XII, L.P., a Delaware limited partnership ("WP XII GP"), is the general partner of the WP XII Funds. WP Global LLC, a Delaware limited liability company ("WP Global"), is the general partner of WP XII GP. Warburg Pincus Partners II, L.P., a Delaware limited partnership ("WPP II"), is the managing member of WP Global. Warburg Pincus Partners II Holdings, L.P., a Delaware limited partnership ("WPP II Holdings"), is a limited partner of WPP II. Warburg Pincus Partners GP LLC, a Delaware limited liability company ("WPP GP"), is the general partner of WPP II and WPP II Holdings. Warburg Pincus & Co., a New York general partnership ("WP"), is the managing member of WPP GP. (Cont'd in FN3)
(Cont'd from FN2) Warburg Pincus LLC, a New York limited liability company ("WP LLC") is a registered investment adviser and the manager of the WP XII Funds. Investment and voting decisions with respect to the shares held by the WP XII Funds are made by a committee comprised of three or more individuals and all members of such committee disclaim beneficial ownership of the shares.